Alka Chaubey's most recent trade in Bionano Genomics Inc was a trade of 24 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 03 Jun 2025 | 24 | 713 (0%) | 0% | 3.7 | 89 | Common Stock |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 6,966 | 6,966 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 15 Feb 2025 | 18 | 737 (0%) | 0% | 5.7 | 103 | Common Stock |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. | 11 Sep 2024 | 3,075 | 45,323 (0%) | 0% | 0.5 | 1,476 | Common Stock |
| Bionano Genomics Inc | Alka Chaubey | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Alka Chaubey | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 16,000 | 48,245 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Alka Chaubey | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 15 Feb 2024 | 1,081 | 31,487 (0%) | 0% | 1.3 | 1,373 | Common Stock |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 560,000 | 560,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 120,000 | 124,794 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 550,000 | 550,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Alka Chaubey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) |